NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 910.50
-6.15 (-0.67%)
Aug 10, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 163.08 billion as of August 10, 2026. Its market cap has increased by 0.30% in one year.
Market Cap
163.08B
Enterprise Value
148.93B
Revenue
40.78B
Ranking
n/a
PE Ratio
11.50
Stock Price
910.50
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 163.08B, an increase of 37,879.48%. That is a compound annual growth rate of 24.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 163.08B | 0.82% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 375.08B |
| Wockhardt | 328.40B |
| Piramal Pharma | 278.11B |
| Eris Lifesciences | 191.56B |
| Cohance Lifesciences | 170.53B |
| Alivus Life Sciences | 163.22B |
| Alembic Pharmaceuticals | 163.17B |
| Sudeep Pharma | 108.15B |